A Phase 2, randomized, placebo-controlled, subject and investigator blinded, multi-center study…06/09/2020 - 06/09/2023 (PI)
Novartis Pharma Corp
Myocardial ischemia and Transfusion (MINT)-CCC06/01/2017 - 05/31/2022 (PI)
Rutgers, New Jersey Medical School NIH-NHLBI